- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04960345
Comparison Between Brainlab Knee 3 Computer-assisted Navigation Systems and Conventional Instruments in TKA: a Prospective Cohort Study.
July 4, 2021 updated by: Peking University Third Hospital
Comparison of Accuracy and Clinical Outcomes Between Brainlab Knee 3 Computer-assisted Navigation Systems and Conventional Instruments in TKA: a Prospective Cohort Study
This is a a prospective cohort study.
According to the inclusion criteria, volunteers were recruited from patients undergoing total knee arthroplasty.
The patients are devided into two groups: the conventional TKA,the computer-assisted surgery(CAS) using Brainlab Knee 3 system.The differences of postoperative alignment,operative time,blood loss will be studied between the two groups.Clinical and functional evaluation using the scoring system of HSS(Hospital for Special Surgery) score, Western Ontario and McMaster University osteoarthritis index (WOMAC), Forgotten joint score(FJS-12) will be compared between the 2 groups,after surgery, and at the follow-up of 3 months、6 months and 12 months.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
According to the inclusion criteria, patients receiving primary total knee arthroplasty were recruited and divided into two groups after doctor-patient joint decision: the traditional group underwent prosthesis placement using traditional intramedullary positioning method;The navigation group performed surgery using the Brainlab Knee 3 navigation system.Informed consent was signed after grouping.
All patients were operated by the same knee prosthesis system.
Both groups underwent the same procedures such as the installation of the soft tissue adjustment, prosthesis placement, wound closure and so on.All patients were given the same perioperative treatment, such as hemostasis, anti-infection and analgesia, and routine postoperative rehabilitation exercises.
The full length anteroposterior and lateral radiographs of both lower extremities in weight-bearing position were taken preoperatively and one week postoperatively.The differences of postoperative alignment,operative time,blood loss will be studied between the two groups.Clinical and functional evaluation using the scoring system of HSS(Hospital for Special Surgery) score, Western Ontario and McMaster University osteoarthritis index (WOMAC), Forgotten joint score(FJS-12) will be compared between the 2 groups,after surgery, and at the follow-up of 3 months、6 months and 12 months.
Study Type
Observational
Enrollment (Anticipated)
188
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Hua Tian
- Phone Number: 13511065187
- Email: tianhua@bjmu.edu.cn
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with knee osteoarthritis who underwent primary TKA
Description
Inclusion criteria:
- Patients with knee osteoarthritis who underwent primary TKA;
- Informed consent has been signed and medical records are complete;
- No severe varus or valgus deformity of the knee (< 20°).
Exclusion criteria:
- Patients undergoing revision knee replacement;
- patients with rheumatoid arthritis and secondary knee osteoarthritis;
- Patients with severe valgus deformity(≥ 20°);
- Taking anticoagulant drugs for a long time in the past, or suffering from the following diseases: Renal insufficiency, liver insufficiency, severe heart disease (or coronary stent implantation within the last 12 months), severe respiratory disease, history of deep vein thrombosis in the lower extremities or a high risk of thrombosis (hereditary/acquired thrombosis), coagulation dysfunction, stroke, and malignancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
The traditional group
The traditional group underwent prosthesis placement using traditional intramedullary positioning method.
|
|
|
The navigation group
The navigation group performed surgery using the Brainlab Knee 3 navigation system.Informed consent was signed after grouping.
|
Brainlab knee 3 navigation system is a kind of imageless computer-assisted navigation system.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
lower limb alignment
Time Frame: Within 1 week after surgery
|
knee-ankle angle (HKA) and components placement using coronal femoral-component angle (CFA) and coronal tibia- component angle (CTA)、sagittal femoral-component angle (SFA) and sagittal tibia-component angle(STA).
|
Within 1 week after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Operation time
Time Frame: Immediately after surgery
|
Time from skin incision to wound closure.
|
Immediately after surgery
|
|
Blood loss
Time Frame: 3 days after surgery
|
Postoperative drainage volume refers to the drainage volume of the affected knee within 24 hours after the end of surgery, accurate to ml.Gross linear equation was used to calculate the total blood loss and latent blood loss at 3 days after surgery.
|
3 days after surgery
|
|
the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Time Frame: 3 months、6 months and 12 months after surgery
|
The WOMAC is a self administered questionnaire to assess joint function and quality of life for patients with osteoarthritis; it consists of 24 items: pain (5 items), stiffness (2 items), and physical function (17 items).
The higher the total score, the worse the patient's pain, stiffness, and functional limitations.
The WOMAC is validated for various languages, including Chinese.
|
3 months、6 months and 12 months after surgery
|
|
HSS(Hospital for Special Surgery) score
Time Frame: 6 months and 12 months after surgery
|
HSS(hospital for special surgery) score HSS(hospital for special surgery) score to evaluate patients postoperative knee joint function.
With a total of 100, it has 7 subscales: 1.Pain 0~30; 2. Function 0~22; 3. Mobility 0~18; 4. Flexion deformity 0~10; 6. Stability 0~10; 7. Deduction Item.
For each scale, a higher value represents a better outcome.
The sum of the subscales is the total score.
|
6 months and 12 months after surgery
|
|
Forgotten Joint Score-12 (FJS-12)
Time Frame: 6 months and 12 months after surgery
|
The FJS-12 is a PROM for patients who have undergone a TKA; it introduces the concept of a "forgotten" joint as the ideal objective to pursue in prosthetic surgery.
It is composed of 12 items, measuring the patient's ability to forget the presence of an artificial joint in their daily life.
For each item, there is a five-points Likert scale response.
The raw results are converted to a 0-100 points scale.
Highest score corresponds to good outcome with the patient not aware about the presence of the prosthesis.
In the case of more than 4 answers are missing, the score should not be used .
|
6 months and 12 months after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
January 1, 2022
Primary Completion (Anticipated)
December 31, 2022
Study Completion (Anticipated)
December 31, 2023
Study Registration Dates
First Submitted
July 4, 2021
First Submitted That Met QC Criteria
July 4, 2021
First Posted (Actual)
July 13, 2021
Study Record Updates
Last Update Posted (Actual)
July 13, 2021
Last Update Submitted That Met QC Criteria
July 4, 2021
Last Verified
July 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- navigation68480
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.